An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person posted that they had to stop their weight-loss medication for a few weeks around surgery, then restarted and saw their weight drop back down within a few days. In plain terms: they paused the drug before an operation, their weight went up while off it, they resumed the drug and a few days later the scale showed a noticeable decrease, and they wrote that the medication “absolutely does wonders.” The drug they’re talking about is called Mounjaro, which is the brand name for tirzepatide. That’s a type of injectable medicine that people use for weight loss and blood sugar control. It mimics hormones your gut makes after you eat that help signal to your brain that you’re full, and it also slows how quickly food leaves your stomach. That combination can lower appetite and reduce how much you eat, which often causes weight loss over time. What the post actually shows is a single person’s short timeline: they stopped the medication for about three weeks around surgery, their weight rose from 203 to about 217 pounds during the break, and within four days after restarting the medication the scale read about 208 pounds. That’s an anecdote — one person’s experience — not a controlled study. Anecdotes can be suggestive, but they don’t prove cause and effect. Rapid swings on a home scale can also reflect fluid changes, bowel contents, or normal day-to-day variation, not just fat loss. Why people care: lots of readers are curious because drugs like tirzepatide have been in the headlines for helping many people lose weight. For someone who’s been making progress, an example of quick improvement after restarting medication is encouraging. If you or someone you know is using or considering this class of drugs, stories like this can feel hopeful and may motivate people to talk with their doctor about options and timing around surgery or other interruptions. Important caveats: this is one person’s report, not proof of how the drug works for everyone. Short-term drops on a scale don’t necessarily equal lost fat. Stopping and restarting these medicines should be done under medical guidance, especially around surgery, because doctors often advise temporary pauses for safety. These drugs can have side effects — nausea, digestive upset, low blood sugar (if you’re also on diabetes meds), and less commonly other issues — and they’re prescription-only. Long-term effects and how quickly weight comes back after stopping vary between people. Bottom line: a single patient’s quick rebound after restarting tirzepatide is encouraging to them, but it’s an anecdote; talk with your clinician for personalized, safe advice.
Source: r/Mounjaro